发明名称 |
DOSAGE FORMS OF APIXABAN |
摘要 |
The present invention relates to a Factor Xa inhibitor dosage form comprising apixaban in a solubility-improved form wherein the dosage form provides controlled release of apixaban and methods for preventing or treating venous thromboembolisms, deep vein thrombosis and acute coronary syndrome with said dosage form. |
申请公布号 |
US2014335178(A1) |
申请公布日期 |
2014.11.13 |
申请号 |
US201414281041 |
申请日期 |
2014.05.19 |
申请人 |
PFIZER INC. ;BRISTOL-MYERS SQUIBB COMPANY |
发明人 |
Nause Richard G. |
分类号 |
A61K47/38;A61K9/20;A61K31/4545 |
主分类号 |
A61K47/38 |
代理机构 |
|
代理人 |
|
主权项 |
1. A dosage form comprising:
a solubility-improved form of apixaban wherein said dosage form provides controlled release of apixaban. |
地址 |
New York NY US |